AFMD News and Press, Affimed N.V. From 05/28/24

Orkla ASA ADR (ORKLY) is expected to report for Q1 2024 Cosmos Health Inc. (COSM) is expected to report $-0.14 for Q1 2024 Basilea Pharmaceutica AG Registered Shares (BPMUF) is expected to report for Q1 2024 DCC Plc (DCCPF) is expected to report for Q4 2024 Datatec Ltd ADR (DTTLY)...

2024-05-26 08:00:00 ET More on related stocks: After Doubling, A Downgrade For DICK'S Sporting Goods Is Prudent Salesforce: A Strong Buy Before Q1 Earnings Digital Turbine Q4 Earnings Preview: Potential Inflection Point Gap expected to surprise Wall Street wi...

In 15 response-evaluable patients with metastatic EGFR wild-type NSCLC, who were pretreated with platinum doublet chemotherapy and checkpoint inhibitors, the combination of AFM24 and atezolizumab led to a disease control rate of 73.3% (11/15), including 4 objective responses (1 complete and 3 par...

2024-05-19 08:02:00 ET Retailers will also be in the spotlight, with updates anticipated from Target ( NYSE: TGT ), Lowe's ( LOW ), Macy’s ( M ), Ross Stores ( ROST ), TJX Companies ( TJX ), Ralph Lauren ( RL ) and Urban Outfitters ( URBN ).... R...

Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML), led to dose-dependent tumor growth control in a validated in vivo mouse model AFM28 led to an effective reduction of CD123-expressing AML patie...

The preliminary results from the phase 2 study investigating AFM24 in combination with the checkpoint inhibitor atezolizumab in patients with EGFR wild-type non-small cell lung cancer have been accepted for poster presentation MANNHEIM, Germany, April 24, 2024 (GLOBE NEWSWIRE) -- Affimed N....

2024-03-28 12:04:42 ET Affimed N.V. (AFMD) Q4 2023 Earnings Conference Call March 28, 2024 8:30 AM ET Company Participants Alexander Fudukidis – Head-Investor Relations Andreas Harstrick – Chief Medical Officer and Interim Acting Chief Executive Officer...

Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...

2024-03-28 06:36:57 ET More on Affimed Affimed falls on 1-for-10 reverse stock split Affimed CEO Adi Hoess to step down, Andreas Harstrick appointed interim CEO Seeking Alpha’s Quant Rating on Affimed Historical earnings data for Affimed Financ...

AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer (NSCLC) EGFR -wildtype cohort: one complete response (CR), three partial responses (PR), and seven stable disease patients in the 15 heavily p...